News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Giraudo Bryan
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/26/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/09/2023 |
4
| Giraudo Bryan (COO/CFO) has filed a Form 4 on Gossamer Bio, Inc.|
Txns:
| Disposed/sold 145,000 options to buy
@ $22.1, valued at
$3.2M
Disposed/sold 71,500 options to buy
@ $14.55, valued at
$1M
Disposed/sold 90,000 options to buy
@ $9.79, valued at
$881.1k
Disposed/sold 150,000 options to buy
@ $10.54, valued at
$1.6M
Disposed/sold 265,000 options to buy
@ $11.94, valued at
$3.2M
Granted 96,667 options to buy
@ $0
Granted 47,667 options to buy
@ $0
Granted 60,000 options to buy
@ $0
Granted 100,000 options to buy
@ $0
Granted 176,667 options to buy
@ $0 |
|
| 04/05/2023 |
4
| Giraudo Bryan (COO/CFO) has filed a Form 4 on Gossamer Bio, Inc.|
Txns:
| Bought 55,000 shares
@ $1.0199, valued at
$56.1k
|
|
| 03/22/2023 |
4
| Giraudo Bryan (COO/CFO) has filed a Form 4 on Gossamer Bio, Inc.|
Txns:
| Bought 50,000 shares
@ $0.9687, valued at
$48.4k
Granted 211,500 options to buy
@ $1.21, valued at
$255.9k
|
|
| 01/18/2023 |
4
| Giraudo Bryan (Director) has filed a Form 4 on Protagonist Therapeutics, Inc|
Txns:
| Granted 30,000 options to buy
@ $12.17, valued at
$365.1k
|
|
| 12/09/2022 |
4
| Giraudo Bryan (COO/CFO) has filed a Form 4 on Gossamer Bio, Inc.|
Txns:
| Granted 211,500 options to buy
@ $2.16, valued at
$456.8k
|
|
| 07/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/24/2022 |
4
| Giraudo Bryan (COO/CFO) has filed a Form 4 on Gossamer Bio, Inc.|
Txns:
| Sold 10,722 shares
@ $8.915, valued at
$95.6k
|
|
| 01/10/2022 |
4
| Giraudo Bryan (COO/CFO) has filed a Form 4 on Gossamer Bio, Inc.|
Txns:
| Granted 265,000 options to buy
@ $11.94, valued at
$3.2M
|
|
| 09/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/28/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/25/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/01/2021 |
4
| Giraudo Bryan (CFO) has filed a Form 4 on Gossamer Bio, Inc.|
Txns:
| Granted 45,000 shares
@ $0
Granted 90,000 options to buy
@ $9.79, valued at
$881.1k
|
|
| 10/14/2020 |
4
| Giraudo Bryan (CFO) has filed a Form 4 on Gossamer Bio, Inc.|
Txns:
| Bought 3,000 shares
@ $10.012, valued at
$30k
|
|
| 06/23/2020 |
4
| Giraudo Bryan (CFO) has filed a Form 4 on Gossamer Bio, Inc.|
Txns:
| Bought 2,000 shares
@ $12.9612, valued at
$25.9k
|
|
| 05/29/2020 |
4
| Giraudo Bryan (Director) has filed a Form 4 on Protagonist Therapeutics, Inc|
Txns:
| Granted 15,000 options to buy
@ $16.54, valued at
$248.1k
|
|
| 02/19/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/03/2019 |
4
| Giraudo Bryan (Director) has filed a Form 4 on Protagonist Therapeutics, Inc|
Txns:
| Bought 8,000 shares
@ $5.7025, valued at
$45.6k
|
|
| 09/26/2019 |
4
| Giraudo Bryan (CFO) has filed a Form 4 on Gossamer Bio, Inc.|
Txns:
| Bought 1,121 shares
@ $16.7798, valued at
$18.8k
|
|
| 06/11/2019 |
4
| Giraudo Bryan (Director) has filed a Form 4 on Protagonist Therapeutics, Inc|
Txns:
| Granted 12,000 options to buy
@ $11.8, valued at
$141.6k
|
|
| 06/03/2019 |
4
| Giraudo Bryan (CFO) has filed a Form 4 on Gossamer Bio, Inc.|
Txns:
| Bought 1,000 shares
@ $18.7, valued at
$18.7k
|
|
| 03/26/2019 |
4
| Giraudo Bryan (CFO) has filed a Form 4 on Gossamer Bio, Inc.|
Txns:
| Granted 145,000 options to buy
@ $22.1, valued at
$3.2M
|
|
| 02/12/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/12/2018 |
4
| Giraudo Bryan (Director) has filed a Form 4 on Protagonist Therapeutics, Inc|
Txns:
| Granted 12,000 options to buy
@ $6.98, valued at
$83.8k
|
|
| 05/17/2018 |
4
| Giraudo Bryan (Director) has filed a Form 4 on Protagonist Therapeutics, Inc|
Txns:
| Bought 10,000 shares
@ $6.4566, valued at
$64.6k
Granted 24,000 options to buy
@ $6.45, valued at
$154.8k
|
|
|
|